JP2018535647A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535647A5 JP2018535647A5 JP2018513423A JP2018513423A JP2018535647A5 JP 2018535647 A5 JP2018535647 A5 JP 2018535647A5 JP 2018513423 A JP2018513423 A JP 2018513423A JP 2018513423 A JP2018513423 A JP 2018513423A JP 2018535647 A5 JP2018535647 A5 JP 2018535647A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- ile
- trp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 28
- 108091008153 T cell receptors Proteins 0.000 claims 19
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 19
- 229920001184 polypeptide Polymers 0.000 claims 19
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 18
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 18
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 claims 18
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 13
- 108090000623 proteins and genes Proteins 0.000 claims 13
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 claims 12
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 12
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 claims 12
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 12
- 210000004027 cells Anatomy 0.000 claims 10
- MTCFGRXMJLQNBG-REOHCLBHSA-N L-serine Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 6
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 238000003259 recombinant expression Methods 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 4
- 108091007172 antigens Proteins 0.000 claims 4
- 102000038129 antigens Human genes 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 2
- 210000000265 Leukocytes Anatomy 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 102100020457 HLA-C Human genes 0.000 claims 1
- 101710009010 HLA-C Proteins 0.000 claims 1
- 108010037618 HLA-C*08 antigen Proteins 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 241000713810 Rat sarcoma virus Species 0.000 claims 1
- 201000011231 colorectal cancer Diseases 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022188263A JP7461445B2 (ja) | 2015-09-15 | 2022-11-25 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562218688P | 2015-09-15 | 2015-09-15 | |
US62/218,688 | 2015-09-15 | ||
PCT/US2016/050875 WO2017048593A1 (en) | 2015-09-15 | 2016-09-09 | T cell receptors recognizing hla-cw8 restricted mutated kras |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022188263A Division JP7461445B2 (ja) | 2015-09-15 | 2022-11-25 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018535647A JP2018535647A (ja) | 2018-12-06 |
JP2018535647A5 true JP2018535647A5 (pt) | 2019-10-17 |
JP7185524B2 JP7185524B2 (ja) | 2022-12-07 |
Family
ID=56985686
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018513423A Active JP7185524B2 (ja) | 2015-09-15 | 2016-09-09 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
JP2022188263A Active JP7461445B2 (ja) | 2015-09-15 | 2022-11-25 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022188263A Active JP7461445B2 (ja) | 2015-09-15 | 2022-11-25 | Hla-cw8拘束性の変異krasを認識するt細胞受容体 |
Country Status (15)
Country | Link |
---|---|
US (3) | US10556940B2 (pt) |
EP (2) | EP3901169A1 (pt) |
JP (2) | JP7185524B2 (pt) |
KR (1) | KR20180044428A (pt) |
CN (2) | CN108350059B (pt) |
AU (3) | AU2016323017B2 (pt) |
CA (1) | CA2998869A1 (pt) |
DK (1) | DK3350213T3 (pt) |
ES (1) | ES2879287T3 (pt) |
HK (1) | HK1257902A1 (pt) |
IL (1) | IL257840B2 (pt) |
MX (1) | MX2018003062A (pt) |
SA (1) | SA518391109B1 (pt) |
SG (1) | SG10201913868XA (pt) |
WO (1) | WO2017048593A1 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4339287A3 (en) | 2015-07-31 | 2024-05-22 | Regents Of The University Of Minnesota | Modified cells and methods of therapy |
SG10201913959WA (en) * | 2016-08-02 | 2020-03-30 | The United States Of America As Represented By The Secretary | Anti-kras-g12d t cell receptors |
GB201700621D0 (en) | 2017-01-13 | 2017-03-01 | Guest Ryan Dominic | Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue |
ES2957959T3 (es) | 2017-03-31 | 2024-01-30 | Us Health | Métodos de aislamiento de secuencias de receptores de células T específicos de neoantígenos |
JP7381345B2 (ja) * | 2017-05-16 | 2023-11-15 | ザ・ジョンズ・ホプキンス・ユニバーシティ | Manaボディおよび使用方法 |
JP2020530307A (ja) | 2017-06-30 | 2020-10-22 | インティマ・バイオサイエンス,インコーポレーテッド | 遺伝子治療のためのアデノ随伴ウイルスベクター |
SG11202002425PA (en) | 2017-09-20 | 2020-04-29 | The United States Of America As Represented By The Secretary | Hla class ii-restricted t cell receptors against mutated ras |
AU2018378200A1 (en) * | 2017-12-04 | 2020-07-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | HLA class I-restricted T cell receptors against mutated RAS |
WO2019246286A1 (en) * | 2018-06-19 | 2019-12-26 | Neon Therapeutics, Inc. | Neoantigens and uses thereof |
US20210340215A1 (en) * | 2018-08-16 | 2021-11-04 | Biontech Us Inc. | T cell receptor constructs and uses thereof |
EP3914612A1 (en) * | 2019-01-22 | 2021-12-01 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Hla class ii-restricted t cell receptors against ras with g12r mutation |
CN114026116A (zh) | 2019-02-20 | 2022-02-08 | 弗雷德哈钦森癌症研究中心 | Ras新抗原特异性结合蛋白及其用途 |
US20220175899A1 (en) * | 2019-04-11 | 2022-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer |
CN110172089B (zh) * | 2019-06-11 | 2020-01-07 | 北京鼎成肽源生物技术有限公司 | 一种kras突变多抗原组合、靶向kras突变肿瘤ctl及其应用 |
CN112110995A (zh) * | 2019-06-19 | 2020-12-22 | 上海交通大学医学院 | 肿瘤新抗原多肽及其用途 |
CN112759641B (zh) * | 2019-11-01 | 2023-01-20 | 香雪生命科学技术(广东)有限公司 | 一种识别Kras G12V的高亲和力TCR |
KR20220119439A (ko) | 2019-12-20 | 2022-08-29 | 인스틸 바이오 유케이 리미티드 | 종양 침윤 림프구를 분리하기 위한 장치 및 방법 및 그것의 용도 |
CN111574616B (zh) * | 2020-06-17 | 2021-02-02 | 深圳豪石生物科技有限公司 | 分离的t细胞受体和应用 |
KR20230150336A (ko) | 2021-02-25 | 2023-10-30 | 알로노스 테라퓨틱스 인코포레이티드 | 폴리시스트론 발현 카세트를 포함하는 재조합 벡터 및 이의 사용 방법 |
WO2023150562A1 (en) | 2022-02-01 | 2023-08-10 | Alaunos Therapeutics, Inc. | Methods for activation and expansion of t cells |
CN114920824B (zh) * | 2022-05-27 | 2023-12-05 | 重庆医科大学 | Tcr或其抗原结合片段及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2497552C (en) | 2002-09-06 | 2014-05-27 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
HUE038833T2 (hu) * | 2005-08-05 | 2018-11-28 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Antigénspecifikus T-sejtek létrehozása |
US8383099B2 (en) | 2009-08-28 | 2013-02-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Adoptive cell therapy with young T cells |
CA2812153C (en) | 2010-09-20 | 2020-06-30 | Biontech Ag | Antigen-specific t cell receptors and t cell epitopes |
WO2012129201A1 (en) | 2011-03-22 | 2012-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of growing tumor infiltrating lymphocytes in gas-permeable containers |
IL290105B2 (en) * | 2011-09-15 | 2024-04-01 | Us Health | MAGE-recognizing T cell receptors are restricted to 1HLA–A or HLA–CW7 |
GB201314404D0 (en) | 2013-08-12 | 2013-09-25 | Immunocore Ltd | T Cell Receptors |
CN107223134B (zh) | 2014-11-26 | 2021-11-16 | 美国卫生和人力服务部 | 抗突变的kras的t细胞受体 |
-
2016
- 2016-09-09 US US15/758,954 patent/US10556940B2/en active Active
- 2016-09-09 ES ES16770408T patent/ES2879287T3/es active Active
- 2016-09-09 CN CN201680058891.3A patent/CN108350059B/zh active Active
- 2016-09-09 WO PCT/US2016/050875 patent/WO2017048593A1/en active Application Filing
- 2016-09-09 DK DK16770408.9T patent/DK3350213T3/da active
- 2016-09-09 SG SG10201913868XA patent/SG10201913868XA/en unknown
- 2016-09-09 CN CN202111083392.9A patent/CN115073583A/zh active Pending
- 2016-09-09 IL IL257840A patent/IL257840B2/en unknown
- 2016-09-09 KR KR1020187010326A patent/KR20180044428A/ko not_active Application Discontinuation
- 2016-09-09 MX MX2018003062A patent/MX2018003062A/es unknown
- 2016-09-09 EP EP21162567.8A patent/EP3901169A1/en active Pending
- 2016-09-09 AU AU2016323017A patent/AU2016323017B2/en active Active
- 2016-09-09 CA CA2998869A patent/CA2998869A1/en active Pending
- 2016-09-09 JP JP2018513423A patent/JP7185524B2/ja active Active
- 2016-09-09 EP EP16770408.9A patent/EP3350213B1/en active Active
-
2018
- 2018-03-13 SA SA518391109A patent/SA518391109B1/ar unknown
-
2019
- 2019-01-08 HK HK19100263.9A patent/HK1257902A1/zh unknown
-
2020
- 2020-01-10 US US16/739,310 patent/US11667692B2/en active Active
-
2021
- 2021-02-10 AU AU2021200833A patent/AU2021200833B2/en active Active
-
2022
- 2022-07-26 AU AU2022209229A patent/AU2022209229B2/en active Active
- 2022-11-25 JP JP2022188263A patent/JP7461445B2/ja active Active
-
2023
- 2023-05-01 US US18/310,141 patent/US20230406904A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018535647A5 (pt) | ||
IL273254B1 (en) | HLA type II-restricted T cell receptors against RAS | |
JP2017536825A5 (pt) | ||
JP2015535816A5 (pt) | ||
JP2015525208A5 (pt) | ||
JP2021505136A5 (pt) | ||
JP2020534828A5 (pt) | ||
EP2997042B1 (en) | Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications | |
JP2020511936A5 (pt) | ||
HRP20200376T1 (hr) | Receptori t-stanica protiv ljudskog papiloma virusa 16e7 | |
JP2020521478A5 (pt) | ||
JP2023025108A5 (pt) | ||
JP2019512242A5 (pt) | ||
JP2018048139A (ja) | 治療用ペプチド | |
JP2017524372A5 (pt) | ||
FI3332006T3 (fi) | Uusia anti-PD-L1-vasta-aineita | |
JP2016503295A5 (pt) | ||
RU2018128215A (ru) | Антитела против mica | |
EP3445785B1 (en) | Humanized anti clever-1 antibodies and their use | |
KR20180016321A (ko) | 프로그램화된 세포 사멸 단백질 리간드-1 (pd-l1)에 대한 항체 및 이의 용도 | |
JP2010533498A5 (pt) | ||
CN110662760A (zh) | 人甲胎蛋白特异性t细胞受体及其用途 | |
RU2016124670A (ru) | Химерные антигенные рецепторы, специфичные в отношении рецептора тимусного стромального лимфопоэтина, и способы их применения | |
JP2018512124A5 (pt) | ||
JP2019536426A (ja) | 頭頸部扁上皮がんおよびその他のがんに対する免疫療法で使用するための新規ペプチドおよびスキャフォールド |